Pharmacokinetics of Tiotropium in Subjects With COPD
- Study Title
- To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Teva Identifier
- TBB-COPD-201
- ClinicalTrials.gov Identifier
- NCT01785433
- Study Status
- Completed
- Trial Condition(s)
- COPD
- Interventions
- Drug: Tiotropium HFA BAI 4.5 mcg | Drug: Tiotropium HFA BAI 9.0 mcg | Drug: SPIRIVAֲ® HandiHalerֲ® 18 mcg/day | Drug: Spirivaֲ® Respimatֲ® 5 mcg/day
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 40 Years to 80 Years
- Trial Duration
- 01/01/2013 - 08/01/2013
- Phase
- Phase 1/2
